№5 2018 тп

ONCOLOGY
BULLETIN
OF THE VOLGA REGION Vol. 9, no. 5. 2018
11. Shah K., Gupta S., Ghosh J. et al. Acute non-ST
elevation myocardial infarction following paclitaxel
administration for ovarian carcinoma: a case report
and review of literature // J. Cancer Res. Ther. —
2012. — Vol. 8, №3. — P. 442-444.
12. Chen H.X., Cleck J.N. Adverse effects of anticancer
agents that target the VEGF pathway // Nat. Rev. Clin.
Oncol. — 2009. — Vol. 6, №8. — P. 465-477.
13. Cameron A.C., Touyz R.M., Lang N.N. Vascular
Complications of Cancer Chemotherapy // Can. J.
Cardiol. — 2016. — Vol. 32, №7. — P. 852-862.
14. Moslehi J.J., Deininger M. Tyrosine Kinase Inhibitor-
Associated Cardiovascular Toxicity in Chronic Myeloid
Leukemia // J. Clin. Oncol. — 2015. — Vol. 33, №35. —
P. 4210-4218.
15. Douxfils J., Haguet H. et al. Association Between BCR-
ABL Tyrosine Kinase Inhibitors for Chronic Myeloid
Leukemia and Cardiovascular Events, Major Molecular
Response, and Overall Survival: A Systematic Review
and Meta-analysis // JAMA Oncol. — 2016. — Vol. 2,
№5. — P. 625-632.
16. Orzan F., Brusca A. et al. Severe coronary artery disease
after radiation therapy of the chest and mediastinum:
clinical presentation and treatment // Br. Heart J. —
1993. — Vol. 69, №6. — P. 496-500.
17. Yarnold J., Brotons M.C. Pathogenetic mechanisms
in radiation fibrosis // Radiother. Oncol. — 2010. —
Vol. 97, №1. — P. 149-161.
18. Schultz-Hector S., Trott K.R. Radiation-induced
cardiovascular diseases: is the epidemiologic evidence
compatible with the radiobiologic data? // Int. J.
Radiat. Oncol. Biol. Phys. — 2007. — Vol. 67, №1. —
P. 10-18.
19. Korpela E, Liu SK. Endothelial perturbations and
therapeutic strategies in normal tissue radiation
damage // Radiat Oncol. — 2014. — Vol. 9, №1. —
P. 266-273.
20. Haubner F., Ohmann E., Pohl F. et al. Effects of
radiation on the expression of adhesion molecules
and cytokines in a static model of human dermal
microvascular endothelial cells // Clin. Hemorheol.
Microcirc. — 2013. — Vol. 54, №4. — P. 371-379.
21. Wynn T.A. Cellular and molecular mechanisms of
fibrosis // J. Pathol. — 2008. — Vol. 214, №2. —
P. 199-210.
22. Haydont V., Mathe D., Bourgier C. et al. Induction of
CTGF by TGF-beta1 in normal and radiation enteritis
human smooth muscle cells: Smad/Rho balance
and therapeutic perspective // Radiother. Oncol. —
2005. — Vol. 76, №2. — P. 219-225.
23. Lipson K.E., Wong C., Teng Y., Spong S. CTGF is a
central mediator of tissue remodeling and fibrosis
and its inhibition can reverse the process of fibrosis //
Fibrogenesis Tissue Repair. — 2012. — Vol. 5, №1. —
P. S.1-S.24.
24. Kim E.H., Park A.K. Global analysis of CpG methylation
reveals epigenetic control of the radiosensitivity in
lung cancer cell lines // Oncogene. — 2010. — Vol. 29,
№33. — P. 4725-4731.
25. Diet A., Abbas K., Bouton C. et al. Regulation of
peroxiredoxins by nitric oxide in immunostimulated
macrophages // J. Biol. Chem. — 2007. — Vol. 282,
№50. — P. 36199-36205.
26. Ross C.C., MacLeod S.L. et al. Inactivation of
thrombomodulin by ionizing radiation in a cell-free
system: possible implications for radiation responses
in vascular endothelium // Radiat Res. — 2008. —
Vol. 169, №4. — P. 408-416.
27. López-Fernández T., Martín García A., Santaballa
Beltrán A. et al. Cardio-Onco-Hematology in Clinical
Practice. Position Paper and Recommendations //
Rev. Esp. Cardiol. (Engl Ed). — 2017. — Vol. 70, №6. —
P. 474-486.
Clinical research and experience in oncology
55